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Summary  1 
Canine oral papillomavirus (COPV) infection is used in vaccine development against  2 
mucosal papillomaviruses. The predictable, spontaneous regression of the virally- 3 
induced papillomas makes this an attractive system for analysis of the cellular  4 
immune events associated with wart clearance. A panel of monoclonal antibodies  5 
against canine immune cells was used to determine the timing and phenotype of  6 
immune cell infiltration throughout the wart life cycle in experimental infections.  7 
Influx of lymphocytes coincided with the onset of wart regression. Both CD4+ and  8 
CD8+ cells were present early on in large numbers, with CD4+ cells being the most  9 
numerous. Lymphocytes were concentrated at the dermo-epidermal interface, and  10 
keratinocyte apoptosis was prominent at the onset of regression. These findings, along  11 
with the results of immunohistochemistry using TCRαβ, TCRγδ, CD1a, CD1c,  12 
CD11a, CD11b, CD11c, CD18, CD21and CD49d-specific monoclonal antibodies,  13 
were compared with similar work in the human, ox and rabbit models. There were  14 
important differences between these systems. Unlike bovine papillomavirus lesions,  15 
those of COPV did not have a significant gamma/delta T-cell infiltrate. Furthermore,  16 
COPV lesions had numerous CD4+ cells, unlike regressing cottontail rabbit  17 
papillomavirus lesions. The lymphocyte infiltrate in the dog was similar to that  18 
described in human papillomavirus lesions. The results demonstrate that CD4+ and  19 
CD8+ cell influx marks the onset of wart regression, and indicate that COPV is valid  20 
as a model system for studies of papillomavirus immunity.  21 
  22 
Introduction  23  
3 
Papillomaviruses have been associated with numerous benign lesions including warts  24 
of the skin, oral cavity, larynx and anogenital region (Shah & Howley, 1996). Some of  25 
the lesions regress spontaneously but others prove refractory to treatment (Beutner &  26 
Ferenczy, 1997). The impact of benign papillomavirus infections is increased in  27 
people immunosuppressed either therapeutically or from HIV infection (Palefsky et  28 
al., 1998). In addition to the benign or low-risk human papillomavirus (HPV)  29 
infections of the genital tract (e.g. HPV-6 and -11), there are papillomavirus types  30 
associated with a high risk of progression to malignancy (e.g. HPV-16, -18, -31). The  31 
association between these high-risk papillomaviruses and the development of cervical  32 
carcinoma is strong enough for HPV-16 and HPV-18 to be defined as carcinogens  33 
(Anonymous, 1996) and it now seems possible that all cases of cervical cancer may be  34 
associated with HPV (Walboomers et al., 1999). The high frequency of  35 
papillomavirus infections, the severity of the lesions, and the inadequacy of current  36 
therapies have led to intense efforts to understand the biology and immunity  37 
associated with these viruses. Because of the species and tissue specificity of  38 
papillomaviruses, and their requirement for differentiating epithelia in order to  39 
complete the life cycle (Stanley, 1994a, Stanley, 1994b), only recently have methods  40 
been developed for their propagation in vitro (Frattini et al., 1996, Meyers et al.,  41 
1992, White et al., 1998). Despite this, there remains a need for in vivo studies of  42 
papillomavirus biology and host immunity, indeed animal models have been described  43 
recently as the "gold standard" by which in vitro models should be assessed (Chow &  44 
Broker, 1997). In human papillomavirus infections, the impossibility of knowing  45 
when an infection began and when a wart is about to regress makes examination of the  46 
events in regressing lesions difficult. Clinical biopsies of isolated regressing warts  47 
provide some information on the cellular immune response, but represent only single  48  
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snapshots of regression and so are difficult to interpret. Whilst it is possible to  49 
compare groups of warts in advanced regression with stable or progressing warts,  50 
studies such as these do not provide a complete chronological picture of wart  51 
regression. Animal models of mucosal papillomatosis, such as the canine and bovine  52 
models (reviewed in Campo, 1997, Nicholls & Stanley, 1999, Nicholls & Stanley,  53 
2000) provide an opportunity to obtain a chronological series of biopsies spanning the  54 
entire wart life cycle from infection through to resolution. Canine oral papillomavirus  55 
(COPV) is of particular interest because experimentally-induced papillomas develop  56 
after only 4 to 8 weeks, and the resulting mucosal papillomas undergo rapid and  57 
predictable regression after maturity. Since the dog forms such an effective immune  58 
response to mucosal papillomavirus infection, knowledge of these events may lead to  59 
a better understanding of the key features required to clear persistent papillomavirus  60 
lesions, such as those seen in some HPV infections. COPV resembles some benign  61 
HPV infections, such as recurrent laryngeal papillomatosis, in its ability to cause  62 
persistent and recurrent infections in certain individuals (Nicholls et al., 1999).  63 
Furthermore, the dog has been used as a key model in the development of  64 
papillomavirus vaccines, including those based on heterologous wart extracts (Bell et  65 
al., 1994, Chambers et al., 1960), L1 virus-like particles (Ghim et al., 1995) and L1- 66 
encoding DNA vaccines (our unpublished observations). Clearly, to validate the  67 
canine model, it is important to establish whether the morphological events in  68 
regressing canine oral papillomas are similar to those seen in regressing human  69 
mucosal papillomas.  70 
With the recent availability of an increasing number of immunological reagents for  71 
use in the dog (Moore & Rossitto, 1993, Moore et al., 1990, Moore et al., 1992,  72  
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Moore et al., 1994b), the immunology of canine oral papillomatosis is more amenable  73 
to evaluation. The aim of this study was to understand more clearly the  74 
immunological events in a mucosal papillomavirus model, especially with respect to  75 
the timing of leucocyte influx in relation to wart progression and regression. Weekly  76 
biopsies taken from experimental COPV infections allowed a prospective longitudinal  77 
immunohistochemical evaluation of the events occurring during wart progression and  78 
regression. The data indicate that an influx of both CD4+ and CD8+ lymphocytes  79 
begins just prior to wart regression, with maximum leucocyte influx correlating with  80 
rapid wart resolution.  81 
  82 
Methods  83 
Experimental infection  84 
Two female beagles aged 10-12 weeks, obtained from a colony with no history of  85 
COPV infection, were housed in purpose-built, climate-controlled accommodation.  86 
To minimise the chances of cross-infection to and from other dogs in the unit, the  87 
dogs were housed in an airspace separate from other dogs in the building, with a  88 
virucidal (Virkon, Antec International, Suffolk, UK) footbath at the common entrance  89 
and exit. All staff changed their protective clothing (gown, gloves, boots) on entering  90 
the controlled area.   91 
After a 10 day acclimatisation period, followed by overnight withdrawal of food,  92 
animals were examined and weighed before premedication by intramuscular injection  93 
of acepromazine maleate (0.03 mg/kg) as a sedative, and buprenorphine hydrochloride  94 
(10 µg/kg) as an analgesic. Anaesthesia was induced by intravenous sodium  95 
thiopentone (2.5%) at approximately 10 mg/kg to effect and maintained with  96  
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halothane and oxygen. The mucosa of the upper lip was lightly scarified over an area  97 
approximately 5 mm x 5 mm, using the tip of a scalpel blade, until a light ooze of  98 
blood occurred. An aliquot of 10 µl of homogenised canine oral papilloma extract  99 
(Bell et al., 1994), kindly donated by A. Bennet Jenson, was applied to each site by  100 
pipette and allowed to absorb for a few minutes. The site of challenge was marked by  101 
Indian ink tattoo points in a triangle centred on the site. Twelve sites were infected in  102 
each dog. Control blood samples and biopsies were taken prior to challenge and  103 
weekly thereafter. The maximum wart diameter was measured each week. At the end  104 
of the study, the animals were re-homed.  105 
  106 
Blood sampling and mucosal biopsy preparation  107 
Under general anaesthesia and after pre-infection control biopsies, further weekly  108 
biopsies of the oral mucosa were taken using a 6 mm biopsy punch or scalpel  109 
followed by suturing as appropriate. Where gross lesions had not yet developed, tissue  110 
was taken from the tattoo-marked sites. The biopsies were split and either fixed in  111 
10% neutral buffered formalin or embedded in optimal cutting temperature compound  112 
(OCT, BDH) and frozen in isopentane cooled to its freezing point in liquid nitrogen.  113 
Formalin-fixed samples were processed after 4-8 hours to paraffin wax for routine (5- 114 
7 µm) sectioning. Frozen tissue was stored at -70ºC prior to cryostat sectioning. Blood  115 
samples were taken from the jugular vein during anaesthesia, and the serum frozen at - 116 
20ºC.  117 
  118  
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Immunohistochemistry of serial biopsies  119 
Cyostat sections (7 µm) were fixed in acetone for 2 minutes, then immersed in 0.3%  120 
hydrogen peroxide in 0.1% w/v sodium azide for 10 minutes. After rinsing in PBS for  121 
3 minutes, the sections were incubated in 10% normal goat serum in PBS for 30  122 
minutes. All further incubations were for 30 minutes at room temperature in a  123 
humidified box. The blocking serum was tipped and blotted off before addition of the  124 
1/10 diluted primary antibody (Table 1). Sections were washed in PBS (3 x 5 min.)  125 
before incubation with the 1/400 diluted biotinylated goat anti-mouse IgG1 or IgG2a  126 
(Amersham). After further washes in PBS (3 x 5 minutes), the sections were  127 
incubated with peroxidase-conjugated avidin-biotin complex (Vectastain Elite, Vector  128 
Laboratories) and developed with DAB (0.06% 3,3' diaminobenzidine  129 
tetrahydrochloride, 0.01% hydrogen peroxide in 0.1M Tris pH 7.5) according to the  130 
manufacturer’s instructions. Sections were counterstained with Carazzi's  131 
haematoxylin and mounted in di-butyl-polystyrene-xylene (DPX). Frozen sections  132 
from lymph nodes were used as positive controls. Omission of the primary or  133 
secondary antibody was used as a negative control.  134 
  135 
Cell counting from immunostained sections  136 
Sections were examined by light microscopy with a x25 objective. Positive-staining  137 
cells were counted throughout the epidermis and the uppermost field of underlying  138 
dermis using an eyepiece graticule. All fields extending horizontally from one edge of  139 
the biopsy to the other edge were counted. Each field measured 400 µm square.  140 
Where cells within a graticule subdivision (40 µm square) were so abundant and  141 
closely packed that they were inumerable, the subdivision was allocated a count of ten  142  
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cells. The counts were repeated on two or more different sections and the mean count  143 
per field was calculated.   144 
  145 
ELISA  146 
Flexible PVC microplates were coated with 100 ng per well of purified COPV virions  147 
suspended in carbonate buffer, pH 9.6, at 4°C overnight. The plates were washed with  148 
PBS/0.05% Tween 20 and blotted dry prior to the addition of 100 µl per well of  149 
PBS/Tween containing 2% w/v skimmed milk powder (ELISA diluent) and  150 
incubation at 37°C for 30 minutes. Following further washing, 50 µl aliquots of  151 
tenfold serum dilutions, from samples taken at 0, 7, 8 and 11 weeks post-infection,  152 
were added to duplicate wells of the coated plates. Negative controls received diluent  153 
alone. The plates were re-incubated at 37°C for 1.5 hours, washed again, and  154 
peroxidase-conjugated, rabbit anti-dog IgG (1/500, ICN immunobiologicals) was  155 
added to all wells. Following incubation for a further 1.5 hours and a final wash, the  156 
plates were developed using s-phenylene diamine/peroxide substrate in urea buffer  157 
(Sigmafast). Colour development was stopped with 20% sulphuric acid and  158 
absorbance levels were read at 490 nm using a Molecular Devices plate reader. The  159 
reciprocal of the log10 dilutions was plotted against the absorbance at 490 nm.  160 
  161 
Results  162 
To investigate the events during regression of mucosal papillomas, we obtained a  163 
chronological series of biopsies from beagles experimentally infected with canine oral  164 
papillomavirus. Histological sections from formalin-fixed biopsies enabled  165  
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morphological examination of papilloma regression, and cryostat sections from snap- 166 
frozen biopsies permitted immunophenotypical analysis of the infiltrating cells.  167 
  168 
Wart development and regression  169 
Scarified sites healed completely by one week and the dogs had no signs of  170 
discomfort, such as reluctance to eat, drink or play with their toys. No macroscopic  171 
lesions were found for the first four weeks after infection, so biopsies were taken  172 
randomly from the tattoo-marked infection sites. From week five post-infection,  173 
lesions were visible on the oral mucosa at the sites of infection which had not already  174 
been biopsied. The size of the lesions was recorded (Fig. 1) to enable correlation with  175 
leucocyte influx. The first lesions were raised, focal, smooth, domed, single or  176 
multiple masses similar in colour to surrounding mucosa. Lesions then increased in  177 
size, becoming more pale and firm compared with surrounding mucosa. The surface  178 
became irregularly textured and by eight weeks mature papillomas with multiple  179 
projecting papillae were evident. In the mature eight-week warts, apoptotic  180 
keratinocytes were common, and in places the tips of wart papillae had undergone  181 
focal coagulative necrosis. A prominent lymphocytic infiltrate was present in the  182 
regressing warts, and in many places the infiltrate obscured the dermo-epidermal  183 
interface, accompanied by apoptotic keratinocytes (Fig. 2). Both intracellular and  184 
intercellular oedema were present in keratinocytes within regressing lesions. The  185 
warts began to soften by week nine, and had sloughed or regressed leaving only a  186 
raised base by week 10. By week 11 there were no obvious signs of infection, and the  187 
histological appearance was similar to that of normal canine oral mucosa. No  188 
papillomas developed other than at inoculated sites.   189  
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  190 
Immunohistochemistry of regressing lesions  191 
Preliminary studies on formalin-fixed, paraffin-embedded tissues (Nicholls & Stanley,  192 
1996), using a CD3ε polyclonal antibody (DAKO), confirmed the presence of  193 
numerous T cells within regressing canine oral papillomas. To more accurately  194 
phenotype the inflammatory infiltrate and to establish the timing of leucocyte influx in  195 
relation to wart regression, a chronological series of biopsies was obtained from  196 
beagles infected experimentally with COPV. Frozen sections from weekly biopsies  197 
were processed for immunohistochemistry. Pre-infection control biopsies were used to  198 
establish the number of cells in normal tissues.   199 
In pre-infection controls, small numbers of lymphocytes were present in the  200 
epithelium. Only a few CD4+ cells were present in the epithelium, with a few  201 
perivascular cells in the lamina propria. A few CD8α+ and CD8β+ cells were present  202 
along the basal layer of the epithelium, occasionally in the lamina propria too.  203 
TCRαβ+ cells had a similar distribution. TCRγδ+ cells were scarce, with only an  204 
occasional cell found within the epithelium. Antibodies to CD1a, CD1c, CD11a and  205 
CD11c detected dendritic cells both within the epithelium and lamina propria,  206 
whereas antibodies to CD11b detected dendritic cells in only the lamina propria.  207 
CD18+ cells were present in both epithelium and lamina propria. CD21+ cells were  208 
scarce and located in the lamina propria.  209 
No changes in staining patterns were seen over the first six weeks. By week seven,  210 
foci of inflammation were seen at the edges of the immature papilloma. At this stage,  211 
the central region of the papilloma had very few leucocytes or dendritic cells,  212 
compared with the inflamed edges and the adjacent normal epithelium. The  213  
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inflammatory foci were positive after immunostaining for CD4, concentrated mostly  214 
in the lamina propria. Increased staining for CD8α, CD8β, TCRαβ and CD49d was  215 
seen within both lamina propria and epithelium. Both CD1a and CD1b showed focal  216 
increases in staining in this region, although the effect was not marked. Focal  217 
increases in number of CD11a, CD11c and CD18 positive cells were seen, distributed  218 
in epithelium and lamina propria, whereas CD11b staining was concentrated in the  219 
lamina propria. Although focal increases in staining of CD1 and CD11 antibodies  220 
were seen, the total counts in the sections were not obviously different from those in  221 
earlier weeks. No increase in TCRγδ or CD21 staining was seen.  222 
The amount of staining for CD4, CD8, TCRαβ, TCRγδ, CD18 and CD49d further  223 
increased during week eight (Fig. 3). CD4+ cells were the most abundant and were at  224 
their maximal levels at this week. TCRαβ, TCRγδ, CD18 and CD49d were also at  225 
their peak number at week eight, but were less numerous than CD4+ cells.  226 
At week nine, CD4, CD8, TCRαβ, and CD18 -positive cells remained numerous, with  227 
CD8+ and TCRγδ+ cells reaching their peaks. At this point, the amount of staining for  228 
CD1a, CD1c, CD11a, CD11b, CD11c and CD21 peaked also. The number of TCRγδ+  229 
CD79a and CD21+ cells was comparatively small, comprising below 10% of the  230 
activity of any other antibody. The wart tissue had almost completely regressed by  231 
week nine and there was ulceration over a large fraction of the epithelium. The  232 
ulceration and loss of epithelium made it difficult to determine the location of cells in  233 
densely inflamed areas.  234 
By week 10, the intensity of staining with most of the antibodies had subsided  235 
markedly, although CD18 and CD49d were still prominent. By week 11, all antibodies  236  
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showed levels of staining indistinguishable from the pre-infection control sections.  237 
The cell counts are summarised in Fig. 4.  238 
  239 
ELISA  240 
The serum sample taken as a pre-infection negative control showed low levels of  241 
reactivity to COPV viral particles. Samples taken seven and eight weeks after  242 
infection showed similarly low levels of anti-COPV IgG antibody. By week 11,  243 
however, a marked increase in titre to COPV virions was seen (Fig. 5).  244 
  245 
Discussion  246 
The spontaneous regression of COPV infections described here is typical of lesions  247 
induced by this virus, with only very rare exceptions (Nicholls et al., 1999). The  248 
marked increase in COPV-specific IgG by week 11 after infection is typical of the  249 
response to COPV. Although COPV L1 capsid protein was detected  250 
immunohistochemically in small amounts at week 7 and large amounts at week 8  251 
(data not shown), there is clearly a lag before significant levels of COPV-specific IgG  252 
are detectable in the circulation. The late expression of viral L1 protein, and its  253 
expression in only superficial keratinocytes of the stratum granulosum, may help the  254 
virus evade the immune response by maintaining a state of immune ignorance until  255 
the viral life cycle is nearing completion. Immunity to re-infection seems solid in the  256 
dog, although, as with other papillomavirus infections, it seems that COPV may enter  257 
a state of latency, since we have detected COPV DNA by PCR in oral mucosa after  258 
spontaneous lesion regression (unpublished data). The immunohistochemical analyses  259 
showed a prominent T-cell infiltrate in regressing canine oral papillomas. Previous  260  
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work in the rabbit (Okabayashi et al., 1991, Selvakumar et al., 1997), ox (Knowles et  261 
al., 1996) and human (Coleman et al., 1994) has demonstrated increased lymphocytes  262 
in regressing warts compared with progressing warts, but the chronological analysis  263 
described here in the dog has allowed a more detailed examination of these events. In  264 
the dog, the influx of lymphocytes began just prior to wart regression, and became  265 
maximal during lesion resolution, before returning to pre-infection levels when the  266 
lesions had resolved. Although similar increased leucocyte numbers have been  267 
reported in other species, some important differences are present. In regressing  268 
cottontail rabbit papillomavirus (CRPV)-induced papillomas, dense T-lymphocyte  269 
infiltrates were seen within the basal region of the epidermis and in adjacent dermis  270 
(Okabayashi et al., 1991). This distribution was similar to that seen in COPV lesions,  271 
in which the infiltrate often obscured the interface zone. This pattern of interface  272 
dermatitis is typical of immune-mediated skin disease in the dog and human. In  273 
contrast to COPV lesions, the infiltrate in CRPV warts comprised predominantly  274 
CD8+ lymphocytes within the basal and suprabasal layers of epithelium (Selvakumar  275 
et al., 1997) with no CD4+ cells demonstrable. The scarcity of CD4+ cells in the  276 
CRPV lesions is noteworthy, considering their abundance in the COPV lesions. This  277 
may represent a true biological difference between rabbit and other animals including  278 
dog and human. However, whilst the anti-rabbit CD4 antibody was reported to work  279 
well on spleen sections, it was described as being non-specific on the papilloma  280 
sections, suggesting that further work in the rabbit may be required to address this  281 
issue. Numerous apoptotic keratinocytes were demonstrable in regressing COPV  282 
lesions, with occasional necrosis of the tips of filiform epithelial papillae. It seems  283 
that keratinocyte apoptosis may play an important role in lesion regression, since in  284 
this study it correlated both spatially and temporally with lymphocytic infiltration and  285  
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wart regression. No obvious necrosis was seen associated with the cellular infiltrate in  286 
CRPV lesions (Selvakumar et al., 1997) in which it was thought that the CD8+ cells  287 
within the epithelium were releasing cytokines such as IL-2 or interferon-γ, reducing  288 
viral spread. Secreted cytokines may have attracted leucocytes into the dermis, where  289 
they released TNFα (Hagari et al., 1995), perhaps reducing epidermal growth and  290 
viral gene expression.   291 
CRPV affects haired skin, so the results obtained in the dog need comparing with  292 
another mucosal papillomavirus infection. Bovine papillomavirus type 4 (BPV-4)  293 
provides such an opportunity. In fact there were some important differences from the  294 
data obtained in the rabbit and dog. The infiltrate in regressing BPV-4 papillomas had  295 
numerous CD4+ cells in the dermis (Knowles et al., 1996), a finding confirmed here  296 
in the COPV lesions. In the more superficial layers of the bovine epithelium there  297 
were more CD8+ than CD4+ cells, whilst the basal layers of epithelium had similar  298 
numbers of CD4+ and CD8+ cells. There were increased TCRγδ+ cells in the  299 
superficial epithelium in BPV-4 lesions. The COPV lesions did have an increase in  300 
TCRγδ+ cells, although these formed only a tiny fraction of the total infiltrate.  301 
In the bovine lesions, lymphocyte numbers correlated with regression, with CD4+  302 
cells being the most numerous type (Knowles et al., 1996). The predominance of  303 
CD4+ cells seen also with COPV lesions suggests they are playing a key role, perhaps  304 
with TH1 CD4+ cells activating macrophages, or by cytokine-mediated inhibition or  305 
killing of infected keratinocytes. The timing of the CD4+ cell appearance seen in the  306 
dog is consistent with their playing a primary role, since they appear just before the  307 
onset of regression. This contrasts with the situation seen for CD1+, CD11a-c+ and  308 
CD21+ cells, which peaked only once regression was underway. This suggests a  309  
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secondary function for these cells, perhaps responding to secondary infection from the  310 
loss of epithelial integrity, or responding to tissue necrosis in the regressing wart.  311 
The CD4+ cells in regressing BPV-4 papillomas were present mostly as sub-epithelial  312 
clusters within the dermis, sometimes surrounded by CD8+ and TCRγδ+ cells, but  313 
migrating more into the epithelium once the basal lamina had been breached  314 
(Knowles et al., 1996). Although sub-epithelial foci of CD4+ cells were seen in the  315 
canine lesions, the pattern described for BPV-4 lesions was not prominent. A major  316 
departure from the findings noted in BPV-4 lesions was the paucity of TCRγδ+ cells  317 
in COPV lesions. In the dog, gamma/delta T cells appear to play an important role in  318 
various infectious, immune-mediated, inflammatory and metabolic skin diseases  319 
(Cannon et al., 1998), and the majority of canine epitheliotropic cutaneous T cell  320 
lymphomas are of gamma/delta phenotype (Moore et al., 1994a). Normal canine oral  321 
mucosa has increased numbers of gamma/delta T cells compared with normal canine  322 
haired skin (Cannon et al., 1998) although, from the findings reported here, their role  323 
in clearance of papillomavirus infections seems minor, at least with respect to the  324 
number of cells involved. Ruminants have abundant TCRγδ+ cells, and these were  325 
more numerous than CD8+ cells in the BPV-4 lesions. Immunostaining for the  326 
interleukin-2 receptor, an indicator of T cell activation, showed that half of the CD4+  327 
and CD8+ cells, and three quarters of the TCRγδ+ cells, were positive (Knowles et al.,  328 
1996).  329 
Numerous lymphocytes are seen in regressing human anogenital warts (Coleman et  330 
al., 1994). The scarcity of B-cells (CD21+) seen in COPV lesions was noted also for  331 
the HPV lesions. An increase in number of both CD4+ and CD8+ cells was common  332 
to regressing lesions of both COPV and HPV, as was an increase in the number of  333  
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intraepithelial CD4+ cells during regression. Although lymphocytes were the most  334 
common infiltrating cell in the regressing HPV lesions, macrophages were seen also.  335 
No changes in Langerhans cell number were seen in the regressing HPV lesions,  336 
although dendrites appeared blunted. A different study reported a reduction in CD1a+  337 
Langerhans cell number in low and high grade cervical disease, compared with  338 
normal cervical epithelium (Mota et al., 1998). The Langerhans cells remaining in  339 
cervical disease appeared to upregulate HLA-DQ expression. The COPV lesions had a  340 
late increase in Langerhans cells and dermal dendritic cells, noted after regression had  341 
started. Interestingly, week seven canine papillomas appeared to have fewer  342 
Langerhans cells within the wart epithelium compared with adjacent normal  343 
epithelium, although this effect was not reflected in the mean for the section. The  344 
reduced numbers of Langerhans cells might have been due to their activation and  345 
migration to the draining lymph nodes.   346 
The dog is a useful model of human immunity, playing an important role in toxicity  347 
trials and development of drugs acting on the immune system. Transplant biology also  348 
has been investigated extensively using a canine model. Dogs develop a spectrum of  349 
immunological diseases similar to that seen in humans, and therefore act as a key  350 
large animal model for immunology and immunopathogenesis. Previously, there has  351 
been only a limited number of canine immunological reagents, although the situation  352 
has now changed due to the increasing availability of reagents for use in the dog  353 
(reviewed in Williams, 1997). It is important to exercise caution in extrapolating data  354 
from animal to human models. For example, the immune system of the ruminant has  355 
important differences from that of humans. In humans, gamma/delta T-cells form only  356 
a minority of the peripheral T-lymphocyte pool, whereas they are present in strikingly  357  
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increased numbers in the peripheral blood of ruminants, especially young cattle (Hass  358 
et al., 1993, Hein & Mackay, 1991, Wyatt et al., 1994). Additionally, the normal  359 
white cell count of cattle is different from that of humans, and generally comprises  360 
fewer neutrophils, more lymphocytes, and more eosinophils (Hope, 1998, Jain, 1993).  361 
Canine normal white cell counts fall within the normal ranges quoted for humans  362 
(Hope, 1998, Jain, 1993) and in the dog, the low numbers of gamma/delta T-cells in  363 
normal haired skin (Cannon et al., 1998) are similar to the findings reported in  364 
humans (Alaibac et al., 1992). In the rabbit also, the gamma/delta T cell proportion in  365 
peripheral blood (23%) is relatively high compared with the human (Sawasdikosol et  366 
al., 1993). The bovine neutrophil has a unique third type of cytoplasmic granule and,  367 
unlike human neutrophils, lacks lysozyme (reviewed in Roth, 1994). The biology of  368 
bovine mast cells differs also from that in the human (reviewed in Pastoret, 1998).  369 
Furthermore, the placental structure of cattle is different from that of humans and  370 
other species. The inability to transfer immunoglobulins across the bovine placenta  371 
means that the ox differs from the human in the composition of colostrum and the  372 
leukocyte distribution in neonatal peripheral blood (reviewed in Pastoret, 1998).  373 
Although the rabbit continues to play an important role in studies of papillomavirus  374 
immunity and vaccine development, it should be remembered that B-cell  375 
diversification in the rabbit, unlike that in other mammals, occurs in the lymphoid  376 
tissue of the appendix in a manner analagous to that occurring in the Bursa of  377 
Fabricius in birds (Pastoret et al., 1998).  378 
In summary, these data showed that a predominantly T-cell infiltrate appeared  379 
predominantly at the dermo-epidermal interface just prior to morphological  380 
regression, becoming maximal during the period of rapid wart regression. CD4+ cells  381  
18 
were more abundant than CD8+ cells, and keratinocyte apoptosis was common during  382 
regression. These observations support the findings reported for regressing human  383 
anogenital warts (Coleman et al., 1994) and confirm that the canine system is likely to  384 
be a good model for papillomavirus immunology studies and vaccine development.  385 
Since the response was clearly very effective in clearing mucosal papillomas, effective  386 
therapeutic strategies should aim at stimulating this type of immunity.  387 
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Figure legends 
Fig. 1. Wart progression and regression after experimental infection. The maximum 
wart diameter was measured each week. Infections in Dog 1 () and Dog 2 () 
showed a similar growth pattern. Warts were visible five weeks after infection, and 
grew rapidly to reach their greatest diameter at eight weeks. Regression was rapid, 
with the lesions disappearing by ten weeks post-infection.  
Fig. 2. Histopathology of wart regression. Regressing papillomas were accompanied 
by numerous apoptotic keratinocytes (a), identifiable by their intensely eosinophilic 
cytoplasm and dense, fragmented nucleus (arrowhead). A dense lymphocytic infiltrate 
obscured the dermo-epidermal interface (b). Haematoxylin and eosin. Original 
magnification (a) x 200, (b) x 100. 
Fig. 3. Immunohistochemistry of COPV lesions. Only small numbers of CD8α+ (a) 
and CD4+ (c) lymphocytes are found in normal canine oral mucosa. Eight weeks after 
infection, regressing COPV lesions contain increased numbers of both CD8α+ (b) and 
CD4+ (d) lymphocytes. Original magnification (a, c) x 200, (b, d) x 100. 
Fig. 4. Cell counts during wart progression and regression. The mean cell count per 
field for each cell type shown is plotted against time after infection with COPV. In 
H&E stained sections, an increase in infiltrating lymphocytes can be seen from week 
8, at the onset of wart regression. Quantitative immunohistochemistry reveals that 
CD4+ lymphocytes reached maximum number at this time. For clarity, counts for the 
scarce TCRgd, CD21 and CD79a cells are plotted on a different scale 
Fig. 5. COPV ELISA of sequential serum samples during experimental infection. Pre-
infection control serum ()had low levels of antibody to native COPV virions. 
Although viral L1 capsid protein can be detected immunohistochemically in lesions at 
week 7 () and week 8 (), no increase in capsid antibody is detectable at these 
points. By week 11(), after wart regression, the serum contains high levels of 
antibody to native COPV virions.  
 
 
 
FIG. 1. Wart progression and regression after experimental infection. Infections in both animals showed a 
similar growth pattern. The maximum wart diameter was measured each week. Warts were visible 5 weeks after 
infection and grew rapidly to reach their greatest diameter at 8 weeks. Regression was rapid, with the lesions 
disappearing by 10 weeks postinfection. Infections in both animals showed a similar growth pattern. 
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Fig. 2. Histopathology of wart regression. Regressing papillomas were accompanied by numerous apoptotic 
keratinocytes (a), identifiable by their intensely eosinophilic cytoplasm and dense, fragmented nucleus 
(arrowhead). A dense lymphocytic infiltrate obscured the dermo-epidermal interface (b). Haematoxylin and 
eosin. Original magnification (a) x 200, (b) x 100. 
 
Fig. 3. Immunohistochemistry of COPV lesions. Only small numbers of CD8+ (a) and CD4+ (c) lymphocytes 
are found in normal canine oral mucosa. Eight weeks after infection, regressing COPV lesions contain increased 
numbers of both CD8+ (b) and CD4+ (d) lymphocytes. Original magnification (a, c) x 200, (b, d) x 100.  
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antibody to native COPV virions. 
 
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
1 1.5 2 2.5 3 3.5 4
Log reciprocal serum dilution
A
b
s
o
r
b
a
n
c
e
 
@
 
4
9
0
n
m 
 
TABLE 1. Origin and specificity of primary antibodies  
Clone     Isotype    Specificity and references                            
CA15.8G7  IgG1    TCRαβ, T-cell receptor, major subset (Moore & Rossitto, 1993) 
CA20.8H1  IgG2a    TCRγδ, T-cell receptor, minor subset (Moore et al., 1994b) 
CA9.AG5  IgG1    CD1a, Langerhans cells, dermal dendritic cells (Danilenko et al., 1992, Marchal et al., 1995, Moore et al., 1996) 
CA13.9H11  IgG1    CD1c, Langerhans cells, dermal dendritic cells (Danilenko et al., 1992, Marchal et al., 1995, Moore et al., 1996) 
CA13.1E4  IgG1    CD4, Helper TH2 & inflammatory TH1 T cells, neutrophils (Moore et al., 1992) 
CA9.JD3  IgG2a    CD8α, MHC-I co-receptor, cytotoxic T-cells (Cobbold & Metcalfe, 1994, Moore et al., 1992) 
CA15.4G2  IgG1    CD8β, MHC-I co-receptor, cytotoxic T-cells (Cobbold & Metcalfe, 1994, Moore et al., 1992) 
CA11.4D3  IgG1    CD11a, LFA-1, granulocytes, monocytes, T-cells, NK-cells, Langerhans cells, follicular dendritic cells, Kupffer cells (Danilenko et al.,  
        1992, Marchal et al., 1995, Moore et al., 1996) 
CA16.3E10  IgG1    CD11b, Mac-1, granulocytes, monocytes, some lymphocytes (NK cells?), not Langerhans cells (Danilenko et al., 1992, Moore et al.,    
        1996) 
CA11.6A1  IgG1    CD11c, monocytes, Kupffer cells, granulocytes, Langerhans and dermal dendritic cells (Danilenko et al., 1992, Marchal et al., 1995, Moore et  
        al., 1996) 
CA1.4E9  IgG1    CD18, β2-integrins, thymocytes, most peripheral leucocytes, dermal and epithelial dendritic cells (Danilenko et al., 1992, Marchal et al., 1995,  
        Moore et al., 1990) 
CA2.1D6  IgG1    CD21, B- cells (Cobbold & Metcalfe, 1994, Moore et al., 1992) 
CA4.5B3  IgG1    CD49d, α4 integrin, VLA-4, activated Langerhans cells (Cobbold & Metcalfe, 1994, Moore et al., 1992)           
 